Clinical Trial Update: Overcoming Endocrine Resistance in Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update addressing endocrine resistance in metastatic breast cancer has been posted. The sponsor listed is Consorzio Oncotech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Consorzio Oncotech | Conditions: Metastatic Breast Cancer | Phase 3 | Status: UNKNOWN